表紙
市場調査レポート

血糖測定器:技術、ビジネス機会、特許分析

Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis

発行 Market Intelligence & Consulting Institute (MIC) 商品コード 333059
出版日 ページ情報 英文 30 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
血糖測定器:技術、ビジネス機会、特許分析 Blood Glucose Meter: Technology, Business Opportunity and Patent Analysis
出版日: 2015年06月15日 ページ情報: 英文 30 Pages
概要

当レポートでは、侵襲的/非侵襲的血糖測定器について取り上げ、市場概要と見通し、主要企業30社の相対的強度について検証し、戦略的・特許展開も含めて、体系的な情報を提供しています。

第1章 技術開発

  • 侵襲的血糖測定器
  • 非侵襲的血糖測定器

第2章 特許マイニング

  • 特許データベースの選択
  • 検索キーワードの確認
  • データ選択
  • データ分析
  • 動向分析
    • テキストマイニング
    • データマイニング
    • 研究開発 (R&D) の相対的強度
    • 特許展開分析の結果
    • 特許指数分析の結果

第3章 市場見通し

MICの見通し

付録

用語集

企業リスト

図表

目次
Product Code: RPT15061501

Amid the global economy growth, the number of consumers with diabetes is rising annually in several countries and regions as result of unhealthy diets with high sugar and calorie intakes. Having a blood glucose meter is evidenced to help diabetes patients effectively control blood glucose levels, thereby reducing the risk of complications associated with diabetes. This report provides an overview of invasive and non-invasive blood glucose meters and market outlook and the relative R&D strength analysis of top 30 companies; examines strategic and patent deployments of several established players in the industry such as Dexcom, Medtronic, Abbott, Baxter and Roche Diagnostics.

Table of Contents

1.Technology Development

  • 1.1 Invasive Blood Glucose Meter
  • 1.2 Non-invasive Blood Glucose Meter

2.Patent Mining

  • 2.1 Selecting a Patent Database
  • 2.2 Identifying Search Keywords
  • 2.3 Data Selection
  • 2.4 Data Analysis
  • 2.5 Analysis of Trends
    • 2.5.1 Text Mining
    • 2.5.2 Data Mining
    • 2.5.3 Relative R&D Strength
    • 2.5.4 Result of Patent Deployment Analysis
    • 2.5.5 Results of Patent Index Analysis

3.Market Outlook

MIC Perspecitve

Appendix

Glossary of Terms

List of Companies

List of Topics

Overview of the blood glucose meters, including invasive and non-invasive types

Major technology fields and sectors identified using the data mining technique; also included are top 30 assignees and their R&D strength ranking

A brief outlook for the sales volume and value of the worldwide blood glucose meter market from 2015 to 2019

Worldwide blood glucose meter market share by sector, and by field type

Analysis of 30 blood glucose meter assignees' deployment in 28 corresponding technology fields and also included is matrix analysis of 10 most important blood glucose meter patents

List of Figures

  • Figure 1: Illustration of Blood Glucose Meters
  • Figure 2: Search Flow for Blood Glucose Meter Patents
  • Figure 3: Blood Glucose Meters' Distribution Share by Sector
  • Figure 4: Blood Glucose Meters' Distribution Share by Field Type

List of Tables

  • Table 1: Comparison of Invasive and Non-invasive Blood Glucose Meters
  • Table 2: Key Technology Fields Identified by Text Mining for Blood Glucose Meters
  • Table 3: R&D Strength Ranking of Top 30 Assignees in the Field of Blood Glucose Meters
  • Table 4: Blood Glucose Meter Assignees' Technology Field Deployment Analysis
  • Table 5: Blood Glucose Meter Assignees' Technology Field Deployment Analysis (continued)
  • Table 6: Top 10 Assignees of Blood Glucose Meters
  • Table 7: Matrix Analysis of 10 Most Important Blood Glucose Meter Patents

Companies covered

Abbott, Alfred E. Mann Foundation for Science Research, Animas Corporation, Baxter, Bayer, Cardiac Pacemakers Inc., Cercacor Laboratories, Dexcom, E. Heller & Company, East West Bank, Eyesense AG, GLT Acquisition Corp., Glumetrics Inc., Hudson Bay Master Fund, Isense Corporation, Legacy Good Samaritan Hospital and Medical Center, Lifescan Inc, Markwell Medical Institute, Medisense, Medtronic, Midcap Funding, National Institutes of Health, Oxygen Biotherapeutics, Panasonic, Roche Diagnostics, Sensors for Medicine and Science, Siemens, Silver James H, Therasense, University of New Mexico, Vivomedical Inc., Xoetronics LLC

Back to Top